Current projects

At the University of Birmingham, we have considerable expertise in all aspects of drug discovery from target discovery to novel methods of drug formulation and delivery. There are many interesting projects across the University that offer the potential for translation to patient benefit. We have drawn upon internal and external expertise to review, prioritise and de-risk around 100 assets to create a portfolio of around 20-30 high quality projects. 

Some example projects are listed below, with many more coming through the pipeline.

Lead Academic

Project title

Therapy Area

Professor Zubair Ahmed

Novel repurposing of inhibitors for treatment of neurological disease

Trauma

Dr Paul Badenhorst

Novel small molecule inhibitors of DNA replication

Oncology

Dr Nik Hodges & Professor Jim Tucker

New targets in DNA replication inhibition with novel compounds

Oncology

Professor Claudio Mauro

Novel immune-based approach for targeting inflammatory diseases

Inflammation

Dr Maarten Hoogenkamp

Novel target in cancer treatment

Oncology

Dr Paul Foster

Novel target in cancer treatment

Oncology

Dr Jorge Caamano

Novel mechanism to stimulate anti-tumour immune responses

Oncology

Professor Steve Watson & Dr Pip Nicolson

Novel approaches to blocking thromboinflammation

Cardiovascular disease

Professor Steve Watson & Dr Mark Thomas

Novel nanobody platform for acute coronary syndromes

Cardiovascular disease